Skip to main content

Cytokine Release Syndrome (CRS)

As innovative immunotherapies continue to transform the landscape of cancer care and research, Cytokine Release Syndrome (CRS) has become a significant risk top of mind for medicinal product developers, hospital systems, technology innovators, payers, regulators, and most importantly, patients. There is a unique opportunity to bring together these diverse sets of stakeholders to lay the foundation for a digital risk prediction tool for CRS. In this project, Advancing Digital Capabilities to Enable Digital Risk Prediction for CRS, we will:

  • Establish common definitions, ontologies, and data models for measures of CRS
  • Understand regulatory and technology requirements associated with CRS risk prediction
  • Determine best practices for developing and implementing a risk prediction tool for CRS

Interested in learning how your team can be a part of this critically important effort? Fill out this form and our team will be in touch with next steps!

This field is for validation purposes and should be left unchanged.